Texas conservative admits he was a Trump cultist and

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
265
Quote:
Texas conservative admits he was a Trump cultist and COVID-19 truther — until he actually caught the virus

Tony Green attacked the coronavirus as a “scamdemic,” but then he was forced to face reality in the worst possible form.

“I admit I voted for Donald Trump in 2016,” wrote Green in DallasVoice. “I admit traveling deep into the conspiracy trap over COVID-19. All the defiant behavior of Trump’s more radical and rowdy cult followers, I participated in it. I was a hard-ass that stood up for my ‘God-given rights.’”

A hard-ass, ass-hat; if you will.

He confessed to going down the rabbit hole of conspiracy theories.


“I believed the virus to be a hoax. I believed the mainstream media and the Democrats were using it to create panic, crash the economy and destroy Trump’s chances at re-election,” he said. “And so, believing the pandemic to be a hoax, my partner and I hosted family members on Saturday, June 13. On Sunday, June 14, I woke up sick.”

It wasn’t an easy version of the pandemic either.

“Imagine gasping for air with every step you take,” Green described. “Imagine rubbing Icy Hot all over your head to soothe a painful headache. Imagine your eyes in a bowl of water while you’re still seeing through them. Imagine collapsing and waking up in the ER only to find out COVID-19 attacked your central nervous system, and the doctor had just saved you from a stroke.”

That would be bad enough if it ended there, but it didn’t. It got worse.

It wasn’t just Green, his partner and his parents all got sick. His in-laws went to see their first grandchild, taking his father-in-law’s mother. His father-in-law was ill by that evening. His mother-in-law and her daughter were next.

“Two days later, my father-in-law’s mother got sick. The new mommy and daddy got sick, too. We all tested positive for COVID-19. Only the newborn was spared,” Green said. “My father-in-law and I both went to the hospital on June 24. The virus had attacked my central nervous system, and the staff stopped me from having a stroke.”

His father-in-law’s mother went to the hospital a day later, succumbing to the virus and pneumonia on July 1. The family told Green’s father-in-law about losing his mother as she lay in a hospital bed alone, even though he was in the room next door.

“On the day of her funeral, which was July 14, five more of our family members tested positive for the virus,” said Green. “That evening, my father-in-law was put on a ventilator.”

“You cannot imagine the guilt I feel,” Green went on, noting that his conspiracy theories and his gathering brought about so much suffering. “ You cannot imagine my guilt at having been a denier, carelessly shuffling through this pandemic, making fun of those wearing masks and social distancing. You cannot imagine my guilt at knowing that my actions convinced both our families it was safe when it wasn’t.”

The virus is real, he said. “I am aware of how my bias could discredit me with some, but trust me, you do not want this virus. And you do not want your loved ones suffering and dying from this because you are taking a ‘political stand’ or protecting the economy over their lives.”

He closed by saying that if people don’t start placing greater importance on health and safety than the interruption of their lives, then no person in the United States will be spared.

Read the full editorial.

https://dallasvoice.com/a-harsh-lesson-in-the...-covid-19/

We are all at the precipice of a common heartache.

The next time you’re put out because your favorite spots are closed or because they won’t let you enter without wearing a mask, and you decide to defy them rather than comply because you’re defending your rights and freedoms from being trampled, just remember: Your family and friends may be next.

Is that too harsh? Try imagining someone you care about on life support. Try being the one to pick the only 10 people allowed to attend a funeral for a loved one. But don’t fret; you’ve got time to ponder, because the mortuary is booked out for at least a week.

Now imagine one more thing: That pool party, the mixer or family reunion you’re pushing for resulting in you being cold and alone in a hospital bed, fighting for your life. Imagine the only human contact you feel is a stranger’s rubber glove giving you medication, checking your vitals and changing your diaper.

That is exactly what has happened to our family.

America, this is not going to go away without sacrifice. Either way, we are going to pay a price. Governments are faced with making difficult decisions, and they cannot appease and satisfy everyone.

But to do nothing is to be foolish. To ignore or question the validity of this virus, its contagiousness or the consequences of selfish attitudes is — at this stage — completely stupid.

I am calling myself out first, but now this is personal, and I fell on my sword. And I promise you, if we continue being more worried about the disruption to our lives than we are about stopping this virus, not one American will be spared.

Not one.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 8

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 5

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 39

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Amicus Therapeutics Plans Third Quarter 2025 Earnings Call

Updated Category News Views 159

Amicus Therapeutics to Discuss Q3 2025 Financial Results Amicus Therapeutics (NASDAQ: FOLD) is preparing for an important financial discussion as it will host a conference call on November 4, 2025, at 8:30 a.m. ET. This call aims to provide insights into the company’s financial performance for the quarter ending September 30, 2025. Conference Call Participation...

Continue Reading
Cineplex Inc. Hits New Milestones In Q2 2025 Financials

Updated Category News Views 223

Cineplex Reports Impressive Growth in Second Quarter Financials Cineplex Inc. (TSX: CGX) has announced its financial performance for the second quarter of 2025, revealing remarkable growth across various metrics. The company’s total revenues surged to CAD 361.8 million, representing a robust 30.5% increase compared to the same period last year. This performance can be...

Continue Reading
Pinnacle Mergers & Acquisitions Finalizes $151M Deal with Dream Motor Group

Updated Category News Views 545

Pinnacle Mergers & Acquisitions Completes a Major Sale DALLAS — Pinnacle Mergers & Acquisitions, a premier automotive buy-sell advisory firm, has finalized the significant sale of Toyota of Montgomery and Lexus of Montgomery to the renowned Dream Motor Group, led by famed coach Nick Saban and automotive expert Joe Agresti. The deal is valued at an impressive $151...

Continue Reading
Atria Development Corporation Appoints New Vice President

Updated Category News Views 80

Atria Development Corporation Welcomes New Leadership Atria Development Corporation is thrilled to announce that Durval Terceira has been appointed as the new Vice President of Business Development and Labour Relations. With his impressive background, he brings a wealth of experience that is expected to steer the company towards its future goals. Durval Terceira: An...

Continue Reading
Ark Invest's Strategic Shift: Selling Block Inc. Shares

Updated Category News Views 289

Ark Invest Adjusts Its Strategy Cathie Wood's Ark Invest has recently made headlines by selling off a portion of its holdings in Block Inc. This decision, valued at an impressive $4.8 million, signifies a potential shift in investment strategy ahead of Block's forthcoming earnings report. Investors are closely monitoring this move as it coincides with Block's rising...

Continue Reading